A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

NCT00695669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza A (H5N1) Virus Monovalent Vaccine

Sponsor

GlaxoSmithKline